Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach

被引:4
|
作者
Chen, Yingyin [1 ,2 ]
Chai, Xinyi [1 ]
Zhao, Ying [1 ,3 ,4 ]
Yang, Xinqian [4 ]
Zhong, Caiting [4 ]
Feng, Yihui [1 ,3 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Guangzhou 510405, Peoples R China
[2] Guangzhou Univ Chinese Med, Lingnan Med Res Ctr, Guangzhou 510405, Peoples R China
[3] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Gynecol, Guangzhou 510405, Peoples R China
[4] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou 510405, Peoples R China
关键词
INSULIN-RESISTANCE; RATS;
D O I
10.1155/2021/6843828
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Zishen Yutai Pills (ZSYTP) is a prescription based on traditional Chinese medicine used to treat kidney-deficient pattern in traditional Chinese medicine. It is also widely used clinically for the treatment of polycystic ovary syndrome (PCOS) with positive results. (is study aims to explore the potential pharmacological mechanism of ZSYTP for the treatment of PCOS by a network pharmacology approach. Methods. Compounds were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and Bioinformatics Analysis Tool for Molecular mechanism of Traditional Chinese Medicine and TCM Database@ Taiwan, and the corresponding targets were retrieved from PubChem, Swiss Target Prediction, STITCH, and DrugBank. Meanwhile, PCOS targets were retrieved from the GeneCards database, the Online Mendelian Inheritance in Man database, National Center for Biotechnology Information Database, and DrugBank. Subsequently, multiple network construction and gene enrichment analyses were conducted with Cytoscape 3.8.2 software. Based on the previous results in the study, molecular docking simulations were done. Results. 205 active compounds and 478 ZSYTP target genes were obtained after screening by ADME consideration. 1881 disease-related targets were obtained after removing duplicates. 148 intersection target genes between drug and disease targets were isolated. Gene ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes analysis highlighted multiple gene functions and different signaling pathways to treat PCOS. Further molecular docking demonstrated the practicality of in vivo action of ZSYTP to a certain extent. Conclusions. It is possible that the pharmacological effect of ZSYTP on PCOS is linked to the hypoxia-inducible factor 1 (HIF-1) signaling pathway, improving insulin resistance, the variation on gene expression such as RNA splicing, and regulation of mRNA metabolic process. (is study paves the way for further research investigating its mechanisms.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Network Pharmacology Approach for Predicting Targets of Zishen Yutai Pills on Premature Ovarian Insufficiency
    Feng, Yihui
    Chai, Xinyi
    Chen, Yingyin
    Ning, Yan
    Zhao, Ying
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [2] Effects of Zishen Yutai pills combined with metformin on women with polycystic ovary syndrome undergoing in vitro fertilization
    Zhang, Yu
    Cao, Shan
    Liang, Jun-xia
    Hu, Shu-hong
    Guo, Xu-fang
    Chun-jing, Shi
    Ge, Li-na
    MEDICINE, 2024, 103 (31)
  • [3] Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking
    Dou, Zhengyan
    Li, Qingxian
    Zhang, Jing
    Zhang, Xin
    JOURNAL OF OVARIAN RESEARCH, 2025, 18 (01)
  • [4] The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking
    Wu, Mali
    Liu, Hua
    Zhang, Jie
    Dai, Fangfang
    Gong, Yiping
    Cheng, Yanxiang
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2023, 26 : 11234
  • [5] Network analysis and experimental approach to investigate the potential therapeutic mechanism of zishen yutai pills on premature ovarian insufficiency
    Song, Zifan
    Song, Kuangyu
    Zhao, Hongru
    He, Yuanqiao
    Hu, Jia
    HELIYON, 2023, 9 (09)
  • [6] The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking
    Duan, Liyun
    Jin, De
    An, Xuedong
    Zhang, Yuehong
    Zhao, Shenghui
    Zhou, Rongrong
    Duan, Yingying
    Zhang, Yuqing
    Liu, Xinmin
    Lian, Fengmei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [7] Network pharmacology and molecular docking study of the active ingredients in Saptasaram kashayam for the treatment of Polycystic ovary syndrome
    Rani, T. Santh
    Lakshmi, P. Premitha Rajya
    Devi, Ch Manga
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2023, 60 (02): : 108 - 121
  • [8] Molecular mechanism of Zishen Yutai Pills protecting ovarian reserve in premature ovarian insufficiency: a multi-omics analysis
    Feng, Y.
    Chen, Y.
    Zhong, Z.
    Zhao, Y.
    HUMAN REPRODUCTION, 2022, 37 : I512 - I512
  • [9] A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
    Liu, Lihong
    Du, Bo
    Zhang, Haiying
    Guo, Xiaofei
    Zhou, Zheng
    Xiu, Aihui
    Liu, Chang
    Su, Shiyu
    Ai, Hao
    CHINESE MEDICINE, 2018, 13
  • [10] A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome
    Lihong Liu
    Bo Du
    Haiying Zhang
    Xiaofei Guo
    Zheng Zhou
    Aihui Xiu
    Chang Liu
    Shiyu Su
    Hao Ai
    Chinese Medicine, 13